The Role of ADAM17 in PCOS Pathogenesis: A review Paper

Boren Preap; Kimsor Hong; Jianlin Chen; Jingfei Chen

doi:10.59653/jhsmt.v2i02.632

Authors

Boren Preap Central South University
Kimsor Hong Central South University
Jianlin Chen Central South University
Jingfei Chen Central South University

DOI:

https://doi.org/10.59653/jhsmt.v2i02.632

Keywords:

PCOS, ADAM17, Pathogenesis

Abstract

This review primarily focuses on the Role of metalloproteinase (ADAM 17). Gynecological disease contributes to approximately 4.5% of the worldwide disease burden. Gynecological problems in women of reproductive age are linked to both In terms of diagnosis and treatment. Because there are no defined biomarkers, identifying gynecological disorders, particularly malignancies, has been difficult in most cases, and histopathological exams remained the gold benchmark. M.M.P.s, ADAMs, and ADAMTSs, as well as their endogenous inhibitors (TIMPs), influence the protease-dependent bioavailability of local niche components. ADAM 17 has been implicated in various pathological processes, including inflammatory response, cardiovascular disease, and, recently, ovarian dysfunction. Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women of reproductive age and is characterized by chronic anovulation, insulin resistance, and increased prevalence of cardiovascular risk factors. So far, the PCOS has not assessed the circulating levels of MMPs and their tissue inhibitors (TIMPs). This review will concentrate on the Role of (ADAM17) in regulating gynecological disorder (PCOS) and their consequent modulation for therapeutic intervention.

Downloads

Download data is not yet available.

References

Adamcova, M., Kawano, I., & Simko, F. (2021). The impact of micrornas in renin–angiotensin-system-induced cardiac remodelling. In International Journal of Molecular Sciences (Vol. 22, Issue 9). https://doi.org/10.3390/ijms22094762

Ciebiera, M., Włodarczyk, M., Zgliczyńska, M., Łukaszuk, K., Męczekalski, B., Kobierzycki, C., Łoziński, T., & Jakiel, G. (2018). The role of tumor necrosis factor α in the biology of uterine fibroids and the related symptoms. In International Journal of Molecular Sciences (Vol. 19, Issue 12). https://doi.org/10.3390/ijms19123869

Ciumărnean, L., Milaciu, M. V., Negrean, V., Orășan, O. H., Vesa, S. C., Sălăgean, O., Iluţ, S., & Vlaicu, S. I. (2022). Cardiovascular risk factors and physical activity for the prevention of cardiovascular diseases in the elderly. In International Journal of Environmental Research and Public Health (Vol. 19, Issue 1). https://doi.org/10.3390/ijerph19010207

Deswal, R., Narwal, V., Dang, A., & Pundir, C. S. (2020). The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review. In Journal of Human Reproductive Sciences (Vol. 13, Issue 4). https://doi.org/10.4103/jhrs.JHRS_95_18

Dou, H., Feher, A., Davila, A. C., Romero, M. J., Patel, V. S., Kamath, V. M., Gooz, M. B., Rudic, R. D., Lucas, R., Fulton, D. J., Weintraub, N. L., & Bagi, Z. (2017). Role of Adipose Tissue Endothelial ADAM17 in Age-Related Coronary Microvascular Dysfunction. Arteriosclerosis, Thrombosis, and Vascular Biology, 37(6). https://doi.org/10.1161/ATVBAHA.117.309430

Düsterhöft, S., Babendreyer, A., Giese, A. A., Flasshove, C., & Ludwig, A. (2019). Status update on iRhom and ADAM17: It’s still complicated. In Biochimica et Biophysica Acta - Molecular Cell Research (Vol. 1866, Issue 10). https://doi.org/10.1016/j.bbamcr.2019.06.017

Düsterhöft, S., Lokau, J., & Garbers, C. (2019). The metalloprotease ADAM17 in inflammation and cancer. In Pathology Research and Practice (Vol. 215, Issue 6). https://doi.org/10.1016/j.prp.2019.04.002

Escobar-Morreale, H. F. (2018). Polycystic ovary syndrome: Definition, aetiology, diagnosis and treatment. In Nature Reviews Endocrinology (Vol. 14, Issue 5). https://doi.org/10.1038/nrendo.2018.24

Floyd, R., Gryson, R., Mockler, D., Gibney, J., Duggan, S. N., & Behan, L. A. (2022). The Effect of Time-Restricted Eating on Insulin Levels and Insulin Sensitivity in Patients with Polycystic Ovarian Syndrome: A Systematic Review. In International Journal of Endocrinology (Vol. 2022). https://doi.org/10.1155/2022/2830545

Freeman, E. W., Kroll, R., Rapkin, A., Pearlstein, T., Brown, C., Parsey, K., Zhang, P., Patel, H., & Foegh, M. (2001). Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder. Journal of Women’s Health and Gender-Based Medicine, 10(6). https://doi.org/10.1089/15246090152543148

Gheblawi, M., Wang, K., Viveiros, A., Nguyen, Q., Zhong, J. C., Turner, A. J., Raizada, M. K., Grant, M. B., & Oudit, G. Y. (2020). Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. In Circulation Research (Vol. 126, Issue 10). https://doi.org/10.1161/CIRCRESAHA.120.317015

Giménez-Palomo, A., Gomes-da-Costa, S., Dodd, S., Pachiarotti, I., Verdolini, N., Vieta, E., & Berk, M. (2022). Does metabolic syndrome or its component factors alter the course of bipolar disorder? A systematic review. In Neuroscience and Biobehavioral Reviews (Vol. 132). https://doi.org/10.1016/j.neubiorev.2021.11.026

Grieve, A. G., Xu, H., Künzel, U., Bambrough, P., Sieber, B., & Freeman, M. (2017). Phosphorylation of iRhom2 at the plasma membrane controls mammalian TACE-dependent inflammatory and growth factor signalling. ELife, 6. https://doi.org/10.7554/eLife.23968

Hajam, Y. A., Rani, R., Ganie, S. Y., Sheikh, T. A., Javaid, D., Qadri, S. S., Pramodh, S., Alsulimani, A., Alkhanani, M. F., Harakeh, S., Hussain, A., Haque, S., & Reshi, M. S. (2022). Oxidative Stress in Human Pathology and Aging: Molecular Mechanisms and Perspectives. Cells, 11(3). https://doi.org/10.3390/cells11030552

He, F. F., & Li, Y. M. (2020). Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: A review. In Journal of Ovarian Research (Vol. 13, Issue 1). https://doi.org/10.1186/s13048-020-00670-3

Huffman, A. M., Rezq, S., Basnet, J., Cardozo, L. L. Y., & Romero, D. G. (2021). Sars-cov-2 viral entry proteins in hyperandrogenemic female mice: implications for women with pcos and covid-19. International Journal of Molecular Sciences, 22(9). https://doi.org/10.3390/ijms22094472

Imanaka, S., Maruyama, S., Kimura, M., Nagayasu, M., & Kobayashi, H. (2020). Towards an understanding of the molecular mechanisms of endometriosis-associated symptoms (Review). In World Academy of Sciences Journal (Vol. 2, Issue 4). https://doi.org/10.3892/wasj.2020.53

Ipsa, E., Cruzat, V. F., Kagize, J. N., Yovich, J. L., & Keane, K. N. (2019). Growth Hormone and Insulin-Like Growth Factor Action in Reproductive Tissues. In Frontiers in Endocrinology (Vol. 10). https://doi.org/10.3389/fendo.2019.00777

Islam, R. M., Bell, R. J., Green, S., Page, M. J., & Davis, S. R. (2019). Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. The Lancet Diabetes and Endocrinology, 7(10). https://doi.org/10.1016/S2213-8587(19)30189-5

Jung, Y. J., Tweedie, D., Scerba, M. T., & Greig, N. H. (2019). Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments. In Frontiers in Cell and Developmental Biology (Vol. 7). https://doi.org/10.3389/fcell.2019.00313

Kakoly, N. S., Earnest, A., Teede, H. J., Moran, L. J., & Joham, A. E. (2019). The impact of obesity on the incidence of type 2 diabetes among women with polycystic ovary syndrome. Diabetes Care, 42(4). https://doi.org/10.2337/dc18-1738

Kawai, T., Elliott, K. J., Scalia, R., & Eguchi, S. (2021). Contribution of ADAM17 and related ADAMs in cardiovascular diseases. In Cellular and Molecular Life Sciences (Vol. 78, Issue 9). https://doi.org/10.1007/s00018-021-03779-w

Kostopoulou, E., Anagnostis, P., Bosdou, J. K., Spiliotis, B. E., & Goulis, D. G. (2020). Polycystic ovary Syndrome in Adolescents: Pitfalls in Diagnosis and Management. In Current obesity reports (Vol. 9, Issue 3). https://doi.org/10.1007/s13679-020-00388-9

Kshetrimayum, C., Sharma, A., Mishra, V. V., & Kumar, S. (2019). Polycystic ovarian syndrome: Environmental/ occupational, lifestyle factors; an overview. In Journal of the Turkish German Gynecology Association (Vol. 20, Issue 4). https://doi.org/10.4274/jtgga.galenos.2019.2018.0142

Kunvariya, A. D., Dave, S. A., Modi, Z. J., Patel, P. K., & Sagar, S. R. (2023). Exploration of multifaceted molecular mechanism of angiotensin-converting enzyme 2 (ACE2) in pathogenesis of various diseases. In Heliyon (Vol. 9, Issue 5). https://doi.org/10.1016/j.heliyon.2023.e15644

Lai, W., Li, X., Zhu, H., Zhu, X., Tan, H., Feng, P., Chen, L., & Luo, C. (2020). Plasma luteinizing hormone level affects the brain activity of patients with polycystic ovary syndrome. Psychoneuroendocrinology, 112. https://doi.org/10.1016/j.psyneuen.2019.104535

Light, R. S., Chilcot, J., & McBride, E. (2021). Psychological Distress in Women Living with Polycystic Ovary Syndrome: The Role of Illness Perceptions. Women’s Health Issues, 31(2). https://doi.org/10.1016/j.whi.2020.11.003

Mahata, S. K., & Corti, A. (2019). Chromogranin a and its fragments in cardiovascular, immunometabolic, and cancer regulation. In Annals of the New York Academy of Sciences (Vol. 1455, Issue 1). https://doi.org/10.1111/nyas.14249

Moldovan, G. E., Miele, L., & Fazleabas, A. T. (2021). Notch signaling in reproduction. In Trends in Endocrinology and Metabolism (Vol. 32, Issue 12). https://doi.org/10.1016/j.tem.2021.08.002

Mondal, S., Adhikari, N., Banerjee, S., Amin, S. A., & Jha, T. (2020). Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview. In European Journal of Medicinal Chemistry (Vol. 194). https://doi.org/10.1016/j.ejmech.2020.112260

Murata, H., Tanaka, S., & Okada, H. (2022). The Regulators of Human Endometrial Stromal Cell Decidualization. In Biomolecules (Vol. 12, Issue 9). https://doi.org/10.3390/biom12091275

Neven, A. C. H., Laven, J., Teede, H. J., & Boyle, J. A. (2018). A summary on polycystic ovary syndrome: Diagnostic criteria, prevalence, clinical manifestations, and management according to the latest international guidelines. Seminars in Reproductive Medicine, 36(1). https://doi.org/10.1055/s-0038-1668085

Poulsen, S. B., & Fenton, R. A. (2019). K+ and the renin–angiotensin–aldosterone system: new insights into their role in blood pressure control and hypertension treatment. In Journal of Physiology (Vol. 597, Issue 17). https://doi.org/10.1113/JP276844

Rodriguez Paris, V., & Bertoldo, M. J. (2019). The Mechanism of Androgen Actions in PCOS Etiology. In Medical sciences (Basel, Switzerland) (Vol. 7, Issue 9). https://doi.org/10.3390/medsci7090089

Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022). Inflammation in obesity, diabetes, and related disorders. In Immunity (Vol. 55, Issue 1). https://doi.org/10.1016/j.immuni.2021.12.013

Rostamtabar, M., Esmaeilzadeh, S., Tourani, M., Rahmani, A., Baee, M., Shirafkan, F., Saleki, K., Mirzababayi, S. S., Ebrahimpour, S., & Nouri, H. R. (2021). Pathophysiological roles of chronic low-grade inflammation mediators in polycystic ovary syndrome. In Journal of Cellular Physiology (Vol. 236, Issue 2). https://doi.org/10.1002/jcp.29912

Sabir, S., Akash, M. S. H., Fiayyaz, F., Saleem, U., Mehmood, M. H., & Rehman, K. (2019). Role of cadmium and arsenic as endocrine disruptors in the metabolism of carbohydrates: Inserting the association into perspectives. In Biomedicine and Pharmacotherapy (Vol. 114). https://doi.org/10.1016/j.biopha.2019.108802

Sanchez-Garrido, M. A., & Tena-Sempere, M. (2020). Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies. In Molecular Metabolism (Vol. 35). https://doi.org/10.1016/j.molmet.2020.01.001

Schumacher, N., & Rose-John, S. (2019). Adam17 activity and il-6 trans-signaling in inflammation and cancer. In Cancers (Vol. 11, Issue 11). https://doi.org/10.3390/cancers11111736

Schumacher, N., & Rose-John, S. (2022). ADAM17 orchestrates Interleukin-6, TNFα and EGF-R signaling in inflammation and cancer. Biochimica et Biophysica Acta - Molecular Cell Research, 1869(1). https://doi.org/10.1016/j.bbamcr.2021.119141

Simionescu, G., Doroftei, B., Maftei, R., Obreja, B.-E., Anton, E., Grab, D., Ilea, C., & Anton, C. (2021). The complex relationship between infertility and psychological distress (Review). Experimental and Therapeutic Medicine, 21(4). https://doi.org/10.3892/etm.2021.9737

Sisto, M., Ribatti, D., & Lisi, S. (2021). Organ fibrosis and autoimmunity: The role of inflammation in TGFβ‐dependent EMT. In Biomolecules (Vol. 11, Issue 2). https://doi.org/10.3390/biom11020310

Taghipour, Y. D., Hajialyani, M., Naseri, R., Hesari, M., Mohammadi, P., Stefanucci, A., Mollica, A., Farzaei, M. H., & Abdollahi, M. (2019). Nanoformulations of natural products for management of metabolic syndrome. In International Journal of Nanomedicine (Vol. 14). https://doi.org/10.2147/IJN.S213831

Witchel, S. F., Oberfield, S. E., & Peña, A. S. (2019). Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment with Emphasis on Adolescent Girls. In Journal of the Endocrine Society (Vol. 3, Issue 8). https://doi.org/10.1210/js.2019-00078

Xue, F., Cheng, J., Liu, Y., Cheng, C., Zhang, M., Sui, W., Chen, W., Hao, P., Zhang, Y., & Zhang, C. (2022). Cardiomyocyte-specific knockout of ADAM17 ameliorates left ventricular remodeling and function in diabetic cardiomyopathy of mice. Signal Transduction and Targeted Therapy, 7(1). https://doi.org/10.1038/s41392-022-01054-3

Zehravi, M., Maqbool, M., & Ara, I. (2021). Polycystic ovary syndrome and reproductive health of women: A curious association. In International Journal of Adolescent Medicine and Health (Vol. 33, Issue 6). https://doi.org/10.1515/ijamh-2021-0031

Zeng, X., Xie, Y. jie, Liu, Y. ting, Long, S. lian, & Mo, Z. cheng. (2020). Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity. In Clinica Chimica Acta (Vol. 502). https://doi.org/10.1016/j.cca.2019.11.003

Zhao, H., Zhang, J., Cheng, X., Nie, X., & He, B. (2023). Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. In Journal of Ovarian Research (Vol. 16, Issue 1). https://doi.org/10.1186/s13048-022-01091-0